Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Legros

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Bulletin Du Cancer|July 1, 1994
[Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults]J Fleury, J Tortochaux, M Legros, et al.
Bone Marrow Transplantation|April 1, 1990
High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in FranceP Viens, D Maraninchi, M Legros, et al.
Bulletin Du Cancer|January 1, 1990
[High doses of alkylating agents and bone marrow autograft in ovarian cancer with poor prognosis: a retrospective analysis of 40 patients treated in France]D Maraninchi, P Viens, M Legros, et al.
Lancet (London, England)|March 19, 1994
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationC Gisselbrecht, H G Prentice, A Bacigalupo, et al.
Tissue Antigens|July 21, 2000
Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G moleculesS Fournel, X Huc, M Aguerre-Girr, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Leukemia & Lymphoma|January 1, 1996
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's diseaseJ Fleury, M Legros, P Colombat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term resultsM Legros, J Dauplat, J Fleury, et al.
Leukemia & Lymphoma|May 1, 1997
The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remissionD Blaise, M Attal, J L Pico, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Bulletin Du Cancer|July 1, 1994
[Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults]J Fleury, J Tortochaux, M Legros, et al.
Bone Marrow Transplantation|April 1, 1990
High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in FranceP Viens, D Maraninchi, M Legros, et al.
Bulletin Du Cancer|January 1, 1990
[High doses of alkylating agents and bone marrow autograft in ovarian cancer with poor prognosis: a retrospective analysis of 40 patients treated in France]D Maraninchi, P Viens, M Legros, et al.
Lancet (London, England)|March 19, 1994
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationC Gisselbrecht, H G Prentice, A Bacigalupo, et al.
Tissue Antigens|July 21, 2000
Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G moleculesS Fournel, X Huc, M Aguerre-Girr, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Leukemia & Lymphoma|January 1, 1996
High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's diseaseJ Fleury, M Legros, P Colombat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term resultsM Legros, J Dauplat, J Fleury, et al.
Leukemia & Lymphoma|May 1, 1997
The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remissionD Blaise, M Attal, J L Pico, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Pageof 12